Marker Therapeutics, Inc. (MRKR)
1.27
+0.02
(+1.60%)
USD |
NASDAQ |
Sep 03, 13:13
Marker Therapeutics Net Income (TTM) : -8.707M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.707M |
| March 31, 2026 | -10.90M |
| December 31, 2025 | -12.16M |
| September 30, 2025 | -14.30M |
| June 30, 2025 | -14.61M |
| March 31, 2025 | -12.78M |
| December 31, 2024 | -10.73M |
| September 30, 2024 | -9.634M |
| June 30, 2024 | -10.31M |
| March 31, 2024 | -12.21M |
| December 31, 2023 | -14.05M |
| September 30, 2023 | -14.35M |
| June 30, 2023 | -17.09M |
| March 31, 2023 | -22.24M |
| December 31, 2022 | -27.92M |
| September 30, 2022 | -34.64M |
| June 30, 2022 | -41.35M |
| March 31, 2022 | -43.01M |
| December 31, 2021 | -41.88M |
| September 30, 2021 | -40.62M |
| June 30, 2021 | -35.56M |
| March 31, 2021 | -31.00M |
| December 31, 2020 | -28.71M |
| September 30, 2020 | -25.28M |
| June 30, 2020 | -23.37M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.59M |
| December 31, 2019 | -21.43M |
| September 30, 2019 | -151.91M |
| June 30, 2019 | -150.84M |
| March 31, 2019 | -150.08M |
| December 31, 2018 | -147.96M |
| September 30, 2018 | -15.08M |
| June 30, 2018 | -14.68M |
| March 31, 2018 | -11.76M |
| December 31, 2017 | -10.98M |
| September 30, 2017 | -9.876M |
| June 30, 2017 | -7.993M |
| March 31, 2017 | -0.1255M |
| December 31, 2016 | -2.455M |
| September 30, 2016 | -18.00M |
| June 30, 2016 | -13.41M |
| March 31, 2016 | -37.83M |
| December 31, 2015 | -34.07M |
| September 30, 2015 | -17.68M |
| June 30, 2015 | -21.73M |
| March 31, 2015 | -2.533M |
| December 31, 2014 | -31.26M |
| September 30, 2014 | -34.00M |
| June 30, 2014 | -33.40M |
| March 31, 2014 | -35.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Krystal Biotech, Inc. | 241.46M |
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| SELLAS Life Sciences Group, Inc. | -32.46M |
| Rezolute, Inc. | -81.48M |
| ADMA Biologics, Inc. | 168.96M |